For some people, genuinely yes
albicans (Nobile et al., 2012)
However, benefits can start within the first few weeks, increasing synergistically with continued therapy
Therefore, well-designed, large-scale randomized controlled trials are critically needed to assess ACs efficacy, safety, optimal dosage, and pharmacokinetics in human populations
This dysregulation significantly contributes to the development of diseases such as alcoholic liver disease (ALD), drug-induced liver injury (DILI), and portal hypertensive gastropathy (PHG)
Funding This work was supported by the National Nature Science Foundation of China (32270903 and 32200699), the Start-up Fund for High-level Talents of Qingdao Agricultural University (6651122011)